A new Northwestern Medicine trial will test whether a telehealth-based intervention that addresses three behavioral risk factors at once can modify cancer patients’ lifestyles to improve their outcomes.
An inflammatory signaling protein called interleukin-6 has been linked to the progression of acute myeloid leukemia, representing a potential target for future treatments of the disease.
An emerging therapy showed promise in patients with relapsed B-cell lymphoma who are not ideal candidates for stem cell transplants.
A new study has identified a molecular switch, through a protein called CDK9, that plays an early and critical role in the skin stem cell differentiation process.
Northwestern Medicine investigators have discovered novel mechanisms underlying transcription elongation, the process of synthesizing RNA from DNA.
An immune system kinase promotes tumor inflammation and progression, according to a study published in Nature Communications.
An epigenetic inhibitor increased immune system activity in patients with ovarian cancer.
Investigators have discovered novel cellular pathways behind chemotherapy-resistant glioblastoma cells and a potential biomarker, paving the way for new therapeutic targets.
Northwestern Medicine investigators have discovered novel mechanisms that regulate cellular stress response, according to findings published in the Proceedings of the National Academy of Sciences.
Bicarbonate ions are required for cell growth in some cancers, according to a Northwestern Medicine study.